Canada markets closed

Sonoma Pharmaceuticals, Inc. (SNOA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.2600+0.0572 (+28.21%)
At close: 04:00PM EDT
0.2130 -0.05 (-18.08%)
After hours: 07:59PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-03-31
2022-03-31
2021-03-31
2020-03-31
Total Revenue
12,310
13,272
12,628
18,629
17,928
Cost of Revenue
7,792
8,795
8,635
12,070
9,806
Gross Profit
4,518
4,477
3,993
6,559
8,122
Operating Expenses
Research Development
1,663
207
125
555
1,339
Selling General and Administrative
7,294
8,840
9,755
9,453
14,173
Total Operating Expenses
8,957
9,047
9,880
10,008
15,512
Operating Income or Loss
-4,439
-4,570
-5,887
-3,449
-7,390
Interest Expense
-
-
-
12
16
Total Other Income/Expenses Net
-688
-630
479
-457
3,812
Income Before Tax
-5,111
-5,184
-5,418
-3,902
-3,544
Income Tax Expense
-35
-33
-332
713
29
Income from Continuing Operations
-5,076
-5,151
-5,086
-4,615
-3,573
Net Income
-5,076
-5,151
-5,086
-3,950
-3,308
Net Income available to common shareholders
-5,076
-5,151
-5,086
-3,950
-3,308
Basic EPS
-1.48
-1.52
-1.92
-1.97
-2.24
Diluted EPS
-1.48
-1.52
-1.92
-1.97
-2.24
Basic Average Shares
4,369
3,394
2,653
1,996
1,477
Diluted Average Shares
4,369
3,394
2,653
1,996
1,477